Parnells New Sevoflurane: Streamlining Veterinary Procedures

Parnell has introduced Sevoflurane Inhalation Anesthetic, expanding its anesthesia portfolio to better support veterinary teams across the full procedural workflow. Indicated for the induction and maintenance of general anesthesia in dogs. The product offers clinics a reliable, cost-effective inhalant anesthetic option from an established veterinary supplier. The launch underscores the company’s commitment to providing confidence at every stage of the anesthetic protocol. With Sevoflurane now complementing PropofolVet Multidose, Dexmedetomidine Hydrochloride Injection, CONTRASED (atipamezole hydrochloride), and Isoflurane Inhalation Anesthetic, practices can source a comprehensive anesthesia toolkit from a single, accountable partner.

According to Precedence Research, the Sevoflurane Market was valued at USD 1.15 billion in 2025 and is projected to grow from USD 1.22 billion in 2026 to approximately USD 2.02 billion by 2035, expanding at a CAGR of 5.80% from 2026 to 2035, driven by increasing demand for reliable and cost-effective anesthetic solutions in veterinary practices.

Veterinary professionals place significant trust in the products used during anesthesia, and that responsibility underpins the company’s approach. In a category where consistency and reliability are as critical as cost, the addition of Sevoflurane enhances support for clinics by providing dependable, high-quality options across the entire anesthesia protocol.

Primary Characteristics of Sevoflurane Inhalation Anesthetic are as follows:

• Indicated for both the induction and maintenance of general anesthesia in canines.
• Possesses nonflammable and nonexplosive attributes, contributing to a safer clinical setting.
• Exhibits a rapid induction and recovery profile, aligning with Sevoflurane’s recognized clinical efficacy.
• Offered in 250 mL bottles.
• Features competitive pricing, enabling veterinary practices to control anesthesia expenses while maintaining high quality.

Foundations of Anesthesia & Sedation: 10-Hour RACE-Approved CE Program

Parnell's commitment to veterinary teams extends beyond the product. The Foundations of Anesthesia & Sedation Certificate Program, an online course offering 10 RACE-approved CE hours, is designed to build staff competency and confidence in anesthesia protocols. For practices investing in both clinical excellence and team development, the program complements the portfolio as part of a broader support ecosystem.

A recent report by Precedence Research highlights that the Sevoflurane Market is benefiting from growing adoption of sevoflurane due to its rapid induction and recovery profile.